glp 1 fda approval GLP-1 Medications for Weight Loss: Semaglutide vs Tirzepatide vs Retat – Revolution Health & Wellness FDA Approves Orforglipron, First GLP-1

2 The medical triad Obesity, as well as DM, are conditions associated with a heightened risk of various cancers, including pancreatic, colorectal, breast, or liver cancer, and an increased mortality risk also accompanies them [8]

All GLP-1 agonists should, theoretically, cure Alzheimers dementia but dulaglutide might be more effective than the others

The Case for ALA as an Antioxidant Adjunct A 2018 single-center RCT (N=64) published in the Journal of Dermatological Treatment randomized patients receiving isotretinoin 0.5 mg/kg/day to either vitamin E 400 IU/day plus ALA 300 mg/day or placebo for 16 weeks

Patients using these products should monitor blood glucose closely and discuss their use with healthcare providers